Literature DB >> 34618224

Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity.

Paolo Preziosa1,2, Lorenzo Conti1, Maria A Rocca1,2,3, Massimo Filippi4,5,6,7,8.   

Abstract

In this review, we critically summarize recent findings derived from randomized controlled trials (RCTs), observational studies and meta-analyses that have been published in the last 3 years and that included the effects of DMTs on cognitive performances among their outcomes.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cognition; Disease modifying drugs; Multiple sclerosis

Mesh:

Year:  2021        PMID: 34618224     DOI: 10.1007/s00415-021-10832-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  1 in total

1.  Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews.

Authors:  Bhasker Amatya; Fary Khan; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14
  1 in total
  1 in total

1.  Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion.

Authors:  Massimo Filippi; Maria Pia Amato; Diego Centonze; Paolo Gallo; Claudio Gasperini; Matilde Inglese; Francesco Patti; Carlo Pozzilli; Paolo Preziosa; Maria Trojano
Journal:  J Neurol       Date:  2022-05-24       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.